IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RIBERO, MARIALISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.107
NA - Nord America 2.995
AS - Asia 1.332
SA - Sud America 54
OC - Oceania 8
AF - Africa 4
Totale 9.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.920
GB - Regno Unito 2.699
IT - Italia 653
CN - Cina 547
SE - Svezia 368
TR - Turchia 336
UA - Ucraina 318
DE - Germania 263
KR - Corea 225
IE - Irlanda 183
RU - Federazione Russa 181
NL - Olanda 132
FR - Francia 126
EU - Europa 125
FI - Finlandia 116
IN - India 107
CA - Canada 75
VN - Vietnam 57
CO - Colombia 50
GR - Grecia 19
ID - Indonesia 16
PL - Polonia 16
BE - Belgio 11
UZ - Uzbekistan 10
SG - Singapore 8
AU - Australia 7
HK - Hong Kong 7
DK - Danimarca 6
JP - Giappone 5
CH - Svizzera 3
ES - Italia 3
IR - Iran 3
MY - Malesia 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
BY - Bielorussia 2
LT - Lituania 2
PH - Filippine 2
AO - Angola 1
CD - Congo 1
CL - Cile 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
IL - Israele 1
KZ - Kazakistan 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 9.625
Salva come PNG Salva come JPEG
Città #
Southend 2.651
Chandler 350
Seattle 339
Ashburn 266
Jacksonville 236
Princeton 236
Dublin 182
Beijing 172
Wilmington 170
Redmond 165
Milan 136
Mountain View 113
Sakarya 111
Kent 101
Nanjing 97
Des Moines 86
Bengaluru 67
Serra 66
Ann Arbor 64
Boardman 60
Andover 57
Bogotá 50
Dearborn 50
Saint Petersburg 47
Toronto 47
Shenyang 34
Nanchang 32
Dong Ket 28
Hanover 28
Jinan 28
Ottawa 27
Woodbridge 27
Shanghai 26
Rome 24
Tianjin 22
Berlin 21
Fairfield 19
Medford 18
Bitonto 15
San Diego 14
Warsaw 14
Changsha 13
Hebei 13
Jiaxing 13
Houston 12
Somerville 12
Athens 11
Brussels 11
Guangzhou 10
Pune 10
Redwood City 10
Verona 10
Chicago 9
Fremont 9
Mumbai 9
Ningbo 9
Eitensheim 8
Washington 8
New York 7
Palermo 7
Roxbury 7
Turin 7
Kunming 6
Lanzhou 6
Norwalk 6
Taizhou 6
Zhengzhou 6
Florence 5
Los Angeles 5
Regina 5
Sydney 5
Auburn Hills 4
Bangalore 4
Bühl 4
Hangzhou 4
Hefei 4
Helsinki 4
Hong Kong 4
Legnano 4
Napoli 4
Noginsk 4
Seoul 4
Taiyuan 4
Amsterdam 3
Arcola 3
Bra 3
Catania 3
Cattolica 3
Dallas 3
Frankfurt am Main 3
Fuzhou 3
Grafing 3
Hamburg 3
Kuala Lumpur 3
Lacchiarella 3
Phoenix 3
Prato 3
Putian 3
Reggio Di Calabria 3
Rimini 3
Totale 6.650
Salva come PNG Salva come JPEG
Nome #
Hepatitis B virus infection in dentists and dental students 322
Prevalence of naturally occurring S-gene mutants of hepatitis B virus in HBsAg negative patients with hepatocellular carcinoma and controls 279
Trasmissione verticale dell’infezione da HBV in bambini sottoposti a immunoprofilassi anti-epatite B 159
Mother-infant transmission of hepatitis B virus (HBV) infection in children receiving full passive and active immunoprophylaxis 152
Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction 146
GENOTIPI DELL'HCV IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO PER EPATOCARCINOMA SU CIRROSI 143
The ability of Procleix Ultrio assay to detect HBV DNA in HBsAg positive blood donors 138
Occult hepatitis B virus and hepatocellular carcinoma : a case-control study 136
Analisi dei donatori di sangue RIBA HCV indeterminati con l'uso di peptidi sintetici 136
Prevalenza dell'infezione occulta da HBV in donatori di sangue con anti-HBc-Ag isolato vaccinati contro l'epatite B 130
Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy) 128
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy 124
Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein and hepatitis C recurrence after liver transplantation 122
Polimorfismi genetici degli enzimi N-acetiltransferasi 2 e glutatione-s-transferasi, fumo di tabacco e rischio di epatocarcinoma 119
Reinfection of liver graft by hepatitis B virus in transplant recipients with occult hepatitis B 119
Antibodies to hepatitis C virus in blood donors 116
Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis 116
Occult hepatitis B in patients with hepatocellular carcinoma and controls with and without hepatitis C infection 115
A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone 114
Hepatitis G and C virus coinfection in children 112
Maternal-infant transmission of HCV infection 112
Association between HLA DQB1*03 and HBV-related hepatocellular carcinoma 111
Vertical transmission of hepatitis C virus in infants born to HCV and HIV seropositive mothers 109
A hepatitis B vaccination programme in a group of dental practitioners 108
Hepatitis B virus S-gene mutants in HBsAg positive blood donors and in patients with hepatocellular carcinoma and controls with overt or occult HBV infection 105
Prevalence of S-gene mutants of hepatitis B virus in Italian blood donors and patients with chronic HBV infection 105
Alpha-Interferon therapy in patients with HCV and HGV coinfection : changes in quantitative HCV and HGV RNA levels 104
Acute non-A, non-B hepatitis in Italy: a 16-year prospective epidemiological study. The possible role of hepatitis C virus 104
Infezione occulta da virus dell'epatite B in donatore di cellule staminali emopoietiche e ricevente con mieloma multiplo 101
Hepatitis C outbreak in health-care workers partecipating in pharmacokinetic studies: biochemical, virological and histological outcome 100
N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: A case-control study 98
Prevalence of markers to hepatitis B virus in dentists in eastern Lombardy 97
Antibody to hepatitis C virus in cryptogenic chronic liver disease 96
Antibodies to hepatitis C virus in children with acute or chronic viral hepatitis 94
Changes of antibody titer to hepatitis C virus during Interferon therapy of cryptogenic chronic active liver disease 94
Effect of hepatitis C genotype on mother-to-infant transmission of virus 94
Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies 93
Il ruolo della vaccinazione nella prevenzione dell'epatite virale di tipo B: Aspetti storici ed attualita 93
Detection of antibody to HIV env glycoprotein in blood donors with indeterminate results on Western blotting 93
A long term study of hepatitis G virus coinfection in chronic hepatitis B 93
Long-Term Surveillance of Allogeneic and Autologous Hemopoietic Stem Cell Transplant Recipients Affected by Primary Occult Hepatitis B Virus Infection 92
A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma 91
Antibody to hepatitis C virus in post-transfusion hepatitis 91
Prophylaxis against HCV recurrence after liver transplantation : effect of interferon and ribavirin combination 90
A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma 89
Consensus interferon (CIFN) in combination with ribavirin (RBV) for naive patients with chronic hepatitis C : a multicenter study 89
Hepatitis C virus genotype in anti-HCV-positive hemodialysed patients 89
Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology : a case-control study 88
Anti-HCV response in post-transfusion hepatitis (PTH). 88
Natural history of chronic hepatitis C in children 87
HCV genotype and response to interferon therapy in chronic hepatitis 87
Response to interferon treatment in patients with chronic hepatitis and HCV/HGV coinfection 85
Epidemiology of tetanus 85
L'infezone da virus dell’epatite B nel personale di odontoiatria 85
Alcohol and hepatocellular carcinoma : the effect of lifetime intake and hepatitis virus infections in men and women 85
Prevalence of GB virus-C/hepatitis G virus infection in patients with cryptogenic chronic liver disease and in patients with primary biliary cirrhosis or Wilson's disease 83
Hepatitis B and C virus infection, alcohol drinking and hepatocellular carcinoma : a case-control study in Italy 83
Hepatitis C virus infection and chronic liver disease in children with leukemia in long-term remission 83
Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma : the role of HCV genotypes and the synergism with hepatitis B virus and alcohol 82
Structural and non-structural HCV antibody seroconversion in NANB post-transfusion hepatitis (PTH) 82
Prevalence of 1762T 1764A mutations in the basic core promoter of HBV isolated from patients with hepatocellular carcinoma and controls 81
Transient loss of HGV induced by interferon treatment does not modify the response of HCV in chronic hepatitis 81
A case-control study on hepatitis G virus and hepatocellular carcinoma in Italy 81
Amount and duration of alcohol intake in development of hepatocellular carcinoma : a case-control study in Italy 81
The prevalence of HCV infection in a cohort of pregnant women, the related risk factors and the possibility of vertical trasmission 80
IFN alpha 2B and ribavirin in naive patients with HCV type 1 chronic hepatitis : results after 6 months of therapy 80
Primary liver cancer and occupation in men : a case-control study in a high-incidence area in Northern Italy 80
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment 80
Hepatitis C virus infection in patients with hematological malignancies treated with chemotherapy or bone marrow transplantation (BMT). 80
Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival 79
Influence of GB virus-C/hepatitis G virus infection on the long term course of chronic hepatitis B 79
Hepatitis C virus genotypes : distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe 78
Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinemia 78
Significance of hepatitis C virus genotypes and viral load in patients with "essential" mixed cryoglobulinemia 78
A case-control study on the role of hepatitis C virus genotypes in hepatocellular carcinoma in North Italy 78
Changes of anti-HCV antibodies in chronic hepatitis C during interferon therapy 78
High circulation of hepatitis C virus in drug abusers with acute viral hepatitis :epidemiological and clinical implications 78
Profilassi con Interferone e ribavirina in pazienti HCV-RNA postivi sottoposti a trapianto di fegato: una nuova strategia contro la recidiva di epatite C 78
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake and hepatolithiasis : a case-control study in Italy 77
Reattività anticorpali anti-HBcAg discordanti tra metodiche sono predittive per la presenza di infezioni occulte da HBV? 77
A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C 76
Hepatitis C virus genotypes in patients with essential mixed cryoglobulinemia 76
Quantitation and typing of hepatitis C Virus RNA in patients on interferon and ribavirin prophylaxis after liver transplantation 76
A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy : Brescia HCC Study 75
Profilo sierologico dell'epatite C acuta e cronica post-trasfusionale 75
Persistence of immunity following hepatitis B vaccination in dental practitioners 75
Effetto della terapia antiretrovirale sulla viremia da HCV e sull'epatite C in una coorte di pazienti HIV positivi 73
Influence of GB virus-C/hepatitis G virus infection on the long term course of chronic hepatitis B 70
HGV infection in patients affected with HCV chronic liver disease: prevalence and eligibility to the interferon treatment 68
Experience with interferon-alpha 2B and ribavirin prophylaxis after liver transplantation in HCV RNA positive recipients 66
Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis 65
Infezione da HGV/HGBV-C e da HCV nei dializzati 61
Evolutionary and molecular aspects of surface antigen (HBsAg) gene mutants in blood donors with occult Hepatitis B virus infection 61
Hepatitis G virus infection in cryptogenic chronic liver disease : is there a role ? 61
Occult Hepatitis B in patients with hepatocellular carcinoma and controls with and without hepatitis C virus infection 60
Ribavirin plus alfa interferon in the treatment of chronic hepatitis C unresponsive to alfa interferon 60
Hepatitis C genotype and clinical outcome of compensated cirrhosis type C 60
Risk factors for acquiring HCV infection among blood donors 59
Infezione occulta da virus dell’epatite B in pazienti con epatocarcinoma e controlli con o senza infezione da HCV 58
Hepatitis C viremia in a cohort of blood donors with different RIBA 3.0 results 58
Totale 9.579
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.936
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.936
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019196 0 0 0 0 0 0 0 0 0 0 131 65
2019/2020903 149 30 55 5 53 99 82 59 179 99 84 9
2020/20211.289 60 69 67 3 123 111 97 54 129 82 411 83
2021/2022844 40 15 12 95 39 45 62 37 71 122 98 208
2022/20231.220 176 102 74 194 160 292 17 49 102 15 31 8
2023/2024631 14 62 21 11 112 16 15 250 11 117 2 0
Totale 10.247